Serenova A/S: Financial statements 2019
CVR: 30532228
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Serenova A/S (CVR 30532228) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -36,431 and a net result of DKK -128,464,518 compared with DKK -54,763,180 the year before. Equity in the 2019 report amounted to DKK 90,965,093. The solvency ratio was 70.3%.
- Gross Profit
- DKK -36,431
- Profit/Loss
- DKK -128,464,518
- Equity
- DKK 90,965,093
- Total Assets
- DKK 129,381,809
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -36K | -128.5M | 91M | - |
| 2018 | - | 13K | -54.8M | 219.4M | - |
| 2017 | - | -4.3M | 274.1M | 274.2M | 0 |
| 2016 | - | -9.2M | -104.1M | 50K | 7 |
| 2015 | 153K | - | -33.9M | 61.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Serenova A/S has published its annual report for 2018. Gross profit came to DKK 12,773, and the net result was DKK -54,763,180.
As of April 4, 2019, Robert Thornedahl has joined the board of directors of Serenova A/S.
As of April 4, 2019, Anders Fredslund Pedersen has left the board of directors of Serenova A/S.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.